Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Icariin for Bipolar Disorder and Co-Occurring Substance Use Disorders
NCT01979133Phase 3Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Oct 2013
- Primary completion
- Jun 2015
- Modality
- Nucleic Acid-Directed Small Molecules, Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of icariin in bipolar disorder (BD), cocaine use disorder (CUD), alcohol use disorder (AUD), sponsored by UT Southwestern Medical Center. Started Oct 2013; status: completed.
02
Drugs
icariin
03
Conditions
bipolar disorder (BD)cocaine use disorder (CUD)alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT01979133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01979133.